Facebook Linkedin Twitter
Inside Precision Medicine Protein Inhibitor Could be New Approach for Treating Non-Hodgkin Lymphomas

Immunotherapy

Lymphoma cancer cell that can be targeted by CAR T-cell therapy
News & Features

Protein Inhibitor Could be New Approach for Treating Non-Hodgkin Lymphomas

0
T-cells attacking cancer cell illustration of microscopic photos
News & Features

Targeting Treg Cell Control Protein Enhances Melanoma Immunotherapy

0
Top 10 Immuno-Oncology Startups of 2019
News & Features

Top 10 Immuno-Oncology Startups of 2019

0
Glioma, glioblastoma - brain tumor
News & Features

Tumor Microenvironment Key to Personalized Immunotherapy Treatment

0
Cambridge Epigenetix has launched a discovery and development program for a test to detect colorectal and other cancers
Molecular Dx

Only 40% of Metastatic Colon Cancer Patients Get Guideline-Recommended Genomic Testing

0
Gut bacteria , gut flora, microbiome. Bacteria inside the small intestine such as Akkermansia muciniphila, which is being tested in an at home study by BiomeSense and Pendulum Therapeutics
Molecular Dx

Potential Vaccination for Chronic Diseases Caused by GI Inflammation Targets Gut Microbiome

0
Cancer and DNA
News & Features

Personalis, Merck KGaA Launch Cancer Biomarker Collaboration

0
T-cells attacking cancer cell illustration of microscopic photos
News & Features

Cellectis Reports Proof-of-Concept for “Smart” CAR T-Cells

0
Bladder cancer, light micrograph
News & Features

New Anti-PD-L1 Study Findings Support Immunotherapy for Bladder Cancer

0
Promega to Develop MSI Technology as CDx to Merck’s Keytruda
Molecular Dx

Promega to Develop MSI Technology as CDx to Merck’s Keytruda

0
1...575859...69Page 58 of 69

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine